Summary for Human Papillomavirus Vaccine (Bivalent)


BreastfeedingGeriatricPediatric
  • Trade Name: Cervarix (GSK)
  • Indications: Prevention of human papillomavirus (HPV) types 16 and 18 in females aged 10–25 years old
  • Class: Vaccine
  • Half-life: N/A
  • Clinically important, potentially hazardous interactions with:
    Immunosuppressants

Please login to view the rest of this drug profile.

Page last updated 08/20/2025

Symbol key

Incidence - Help

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness - Help

Hospitalization possible
Life threatening
Fatal

Warnings in other populations - Help

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top